298 related articles for article (PubMed ID: 33582104)
1. Prostate Magnetic Resonance Imaging for Local Recurrence Reporting (PI-RR): International Consensus -based Guidelines on Multiparametric Magnetic Resonance Imaging for Prostate Cancer Recurrence after Radiation Therapy and Radical Prostatectomy.
Panebianco V; Villeirs G; Weinreb JC; Turkbey BI; Margolis DJ; Richenberg J; Schoots IG; Moore CM; Futterer J; Macura KJ; Oto A; Bittencourt LK; Haider MA; Salomon G; Tempany CM; Padhani AR; Barentsz JO
Eur Urol Oncol; 2021 Dec; 4(6):868-876. PubMed ID: 33582104
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Accuracy and Observer Agreement of the MRI Prostate Imaging for Recurrence Reporting Assessment Score.
Pecoraro M; Turkbey B; Purysko AS; Girometti R; Giannarini G; Villeirs G; Roberto M; Catalano C; Padhani AR; Barentsz JO; Panebianco V
Radiology; 2022 Aug; 304(2):342-350. PubMed ID: 35536130
[TBL] [Abstract][Full Text] [Related]
3. An MRI assessment of prostate cancer local recurrence using the PI-RR system: diagnostic accuracy, inter-observer reliability among readers with variable experience, and correlation with PSA values.
Franco PN; Frade-Santos S; García-Baizán A; Paredes-Velázquez L; Aymerich M; Sironi S; Otero-García MM
Eur Radiol; 2024 Mar; 34(3):1790-1803. PubMed ID: 37646815
[TBL] [Abstract][Full Text] [Related]
4. PI-RR: The Prostate Imaging for Recurrence Reporting System for MRI Assessment of Local Prostate Cancer Recurrence After Radiation Therapy or Radical Prostatectomy-A Review.
Abreu-Gomez J; Dias AB; Ghai S
AJR Am J Roentgenol; 2023 Jun; 220(6):852-861. PubMed ID: 36722763
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy.
Gandaglia G; Ploussard G; Valerio M; Marra G; Moschini M; Martini A; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Afferi L; Rakauskas A; Gontero P; Mattei A; Montorsi F; Briganti A
Eur Urol Oncol; 2020 Dec; 3(6):739-747. PubMed ID: 32847747
[TBL] [Abstract][Full Text] [Related]
6. The Transatlantic Recommendations for Prostate Gland Evaluation with Magnetic Resonance Imaging After Focal Therapy (TARGET): A Systematic Review and International Consensus Recommendations.
Light A; Mayor N; Cullen E; Kirkham A; Padhani AR; Arya M; Bomers JGR; Dudderidge T; Ehdaie B; Freeman A; Guillaumier S; Hindley R; Lakhani A; Pendse D; Punwani S; Rastinehad AR; Rouvière O; Sanchez-Salas R; Schoots IG; Sokhi HK; Tam H; Tempany CM; Valerio M; Verma S; Villeirs G; van der Meulen J; Ahmed HU; Shah TT
Eur Urol; 2024 May; 85(5):466-482. PubMed ID: 38519280
[TBL] [Abstract][Full Text] [Related]
7. Multiparametric Magnetic Resonance Imaging Is an Independent Predictor of Salvage Radiotherapy Outcomes After Radical Prostatectomy.
Sharma V; Nehra A; Colicchia M; Westerman ME; Kawashima A; Froemming AT; Kwon ED; Mynderse LA; Karnes RJ
Eur Urol; 2018 Jun; 73(6):879-887. PubMed ID: 29195777
[TBL] [Abstract][Full Text] [Related]
8. S-PI-RADS and PI-RRADS for Biparametric MRI in the Detection of Prostate Cancer and Post-treatment Local Recurrence.
Scialpi M; Martorana E; Scialpi P; Scalera GB; Belatti E; Aisa MC; D'Andrea A; Mancioli FM; DI Marzo A; Trippa F; DI Blasi A
Anticancer Res; 2023 Jan; 43(1):297-303. PubMed ID: 36585156
[TBL] [Abstract][Full Text] [Related]
9. Association Between Multiparametric Magnetic Resonance Imaging of the Prostate and Oncological Outcomes after Primary Treatment for Prostate Cancer: A Systematic Review and Meta-analysis.
Stabile A; Mazzone E; Cirulli GO; De Cobelli F; Grummet J; Thoeny HC; Emberton M; Pokorny M; Pinto PA; Taneja SS
Eur Urol Oncol; 2021 Aug; 4(4):519-528. PubMed ID: 33384275
[TBL] [Abstract][Full Text] [Related]
10. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
Eur Urol; 2014 Feb; 65(2):467-79. PubMed ID: 24321502
[TBL] [Abstract][Full Text] [Related]
11. Magnetic Resonance Imaging-based T-staging to Predict Biochemical Recurrence after Radical Prostatectomy: A Step Towards the iTNM Classification.
Baboudjian M; Gondran-Tellier B; Touzani A; Martini A; Diamand R; Roche JB; Lacetera V; Beauval JB; Roumeguère T; Simone G; Benamran D; Fourcade A; Fiard G; van den Bergh RCN; Peltier A; Ploussard G
Eur Urol Oncol; 2023 Aug; 6(4):406-413. PubMed ID: 36280445
[TBL] [Abstract][Full Text] [Related]
12. The practical clinical role of machine learning models with different algorithms in predicting prostate cancer local recurrence after radical prostatectomy.
Hu C; Qiao X; Hu C; Cao C; Wang X; Bao J
Cancer Imaging; 2024 Feb; 24(1):23. PubMed ID: 38326860
[TBL] [Abstract][Full Text] [Related]
13. Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups.
Mazzone E; Gandaglia G; Ploussard G; Marra G; Valerio M; Campi R; Mari A; Minervini A; Serni S; Moschini M; Marquis A; Beauval JB; van den Bergh R; Rahota RG; Soeterik T; Roumiguiè M; Afferi L; Zhuang J; Guo H; Mattei A; Gontero P; Cucchiara V; Stabile A; Fossati N; Montorsi F; Briganti A
Eur Urol; 2022 Feb; 81(2):193-203. PubMed ID: 34399996
[TBL] [Abstract][Full Text] [Related]
14. The role of multiparametric mri in the diagnosis of local recurrence after radical prostatectomy and before salvage radiotherapy.
Faiella E; Santucci D; Vertulli D; Esperto F; Messina L; Castiello G; Papalia R; Flammia G; Scarpa RM; Fiore M; Trodella LE; Ramella S; Grasso RF; Beomonte Zobel B
Actas Urol Esp (Engl Ed); 2022 Sep; 46(7):397-406. PubMed ID: 35778338
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Significance for Long-Term Outcomes Following Radical Prostatectomy in Men with Prostate Cancer: Evaluation with Prostate Imaging Reporting and Data System Version 2.
Kim R; Kim CK; Park JJ; Kim JH; Seo SI; Jeon SS; Lee HM
Korean J Radiol; 2019 Feb; 20(2):256-264. PubMed ID: 30672165
[TBL] [Abstract][Full Text] [Related]
16. PI-RADS Version 2 Category on 3 Tesla Multiparametric Prostate Magnetic Resonance Imaging Predicts Oncologic Outcomes in Gleason 3 + 4 Prostate Cancer on Biopsy.
Faiena I; Salmasi A; Mendhiratta N; Markovic D; Ahuja P; Hsu W; Elashoff DA; Raman SS; Reiter RE
J Urol; 2019 Jan; 201(1):91-97. PubMed ID: 30577397
[TBL] [Abstract][Full Text] [Related]
17. Multiparametric MRI for recurrent prostate cancer post radical prostatectomy and postradiation therapy.
Barchetti F; Panebianco V
Biomed Res Int; 2014; 2014():316272. PubMed ID: 24967355
[TBL] [Abstract][Full Text] [Related]
18. Prediction of biochemical recurrence after radical prostatectomy with PI-RADS version 2 in prostate cancers: initial results.
Park SY; Oh YT; Jung DC; Cho NH; Choi YD; Rha KH; Hong SJ
Eur Radiol; 2016 Aug; 26(8):2502-9. PubMed ID: 26560721
[TBL] [Abstract][Full Text] [Related]
19. Pathological and 3 Tesla Volumetric Magnetic Resonance Imaging Predictors of Biochemical Recurrence after Robotic Assisted Radical Prostatectomy: Correlation with Whole Mount Histopathology.
Tan N; Shen L; Khoshnoodi P; Alcalá HE; Yu W; Hsu W; Reiter RE; Lu DY; Raman SS
J Urol; 2018 May; 199(5):1218-1223. PubMed ID: 29128577
[TBL] [Abstract][Full Text] [Related]
20. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.
Mottet N; Bellmunt J; Bolla M; Briers E; Cumberbatch MG; De Santis M; Fossati N; Gross T; Henry AM; Joniau S; Lam TB; Mason MD; Matveev VB; Moldovan PC; van den Bergh RCN; Van den Broeck T; van der Poel HG; van der Kwast TH; Rouvière O; Schoots IG; Wiegel T; Cornford P
Eur Urol; 2017 Apr; 71(4):618-629. PubMed ID: 27568654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
